- Category: Research
Research
CooperVision completes global enrollment for largest pediatric myopia control study
Post-approval studies in the U.S. and China will provide real-world evidence on the efficacy of MiSight 1 day in managing myopia.
Research
4-year data shows Vabymso delivers lasting DME results with fewer injections
Open-label extension study demonstrates long-term safety, efficacy, and tolerability of faricimab in DME patients.
Research
Illinois Tech researchers report third implant of wireless visual prosthesis
Groundbreaking brain implant highlights new pathway to providing artificial vision for individuals with blindness.
Research
Should normal-tension glaucoma patients be more closely monitored?
New research suggests certain NTG patients may need closer follow-up due to unstable visual field results.
Research
Vitreous floaters may predict RD development
Cohort study finds new-onset floaters, particularly when acute or numerous, confer a higher absolute risk of retinal detachment than flashes alone.
Research
Low vision rehab less effective in patients with hearing loss
Patients with hearing impairment less likely to achieve clinically meaningful improvement from vision rehabilitation.
Research
Neuvasq highlights novel antibody approach for restoring blood-retina barrier in wet AMD and DME
Preclinical data of NVQ401 and NVQ501 demonstrate improvements in BRB integrity and function in vascular retinopathy models.
Research
Metformin may slow postoperative PCO
Study findings suggest the common diabetes drug may reach the lens capsule and reduce cell activity linked to secondary cataract formation.
Research
PreserVision AREDS3 launch highlights B vitamins’ potential role in AMD
Bausch + Lomb advanced PreserVision formula spotlights the unique B-vitamin complex in reducing the risk for AMD, especially in earlier stages.
Research
Dexamethasone drops may preserve vision in ROP
Low-dose topical dexamethasone at the type 2 ROP stage reduced the need for laser or anti-VEGF treatment by more than 80%.
Research
New IZERVAY findings link GA treatment to improved likelihood of retaining driving eligibility
Post hoc analysis demonstrates IZERVAY reduces risk of progressing to losing driving eligibility in GA patients.
Research
White paper supports Sequel progressive addition lenses for digital eye strain
After 6 weeks, patients experienced an average of 71% reduction in DES symptoms and three-fourths reported no end-of-day fatigue.
Research
Oculis's global DME consensus study identifies critical gaps in care
Expert panel highlights disease management while emphasizing the importance of early intervention and non-invasive treatment options based on BCVA outcomes.
Research
Do anti-VEGF injections increase cataract risk?
A 15-year retrospective study found injected eyes nearly six times more likely to undergo cataract surgery than their untreated fellow eyes.
Research
Real-world TED data finds disease advances beyond acute phase
Real-world study demonstrates heterogeneous disease progression in TED, challenging the traditional self-limited paradigm.
Research
Breakthrough trial finds MiYOSMART iQ spectacle lenses halt childhood myopia progression
Latest 12-month data details highest myopia-control efficacy results reported to date in myopes as young as age 4 wearing HOYA’s D.I.M.S. technology.
Research
Are blue-light blocking IOLs actually effective?
Yellow-tinted lenses were associated with a decline in macular pigment density over 3 years, the opposite of the intended effect.
Research
Epioxa phase 3 pivotal trial supports early intervention for keratoconus management
New findings reinforce epi-on CXL's role in early keratoconus treatment, Glaukos is planning an extension trial for long-term monitoring.
Research
Researchers question safety of red light among pediatric myopes
Laboratory analysis suggests some devices may exceed established retinal safety limits during recommended treatment times.
Research